On (b)(6) 2022, the lay-user/patient contacted lifescan (lfs) france, alleging that their onetouch verio2 meter read inaccurately high compared to their feelings and/or normal readings.The complaint was classified based on the customer care agent (cca) documentation.The patient reported that the alleged meter inaccuracy began on (b)(6) 2022, at 6:30 pm when they obtained an alleged high result of ¿360 mg/dl¿ with the subject meter, and the issue continued for 1 week.The patient uses novomix 30 insulin (6-8 units morning and evening) to manage their diabetes.As a result of the alleged issue, the patient's nurse contacted their doctor who prescribed novorapid insulin to take in additional their normal medication.The patient changed their treatment as advised by their nurse and doctor, and on (b)(6) 2022, at 6:30 pm and (b)(6) 2022, at 5:30 am, they took 5 units of novorapid insulin in addition to 16 units of novomix 30 insulin.The patient indicated that on (b)(6) 2022, at 11:30 am, they developed symptoms of ¿couldn't see or walk properly¿ and ¿walked twisted¿.In response to the symptoms, the patient tested their blood glucose on another meter and obtained a result of ¿54 mg/dl¿.The patient self-treated with cake and 4 sugar cubes and felt better 10 minutes afterwards.At the time of troubleshooting, the cca confirmed the unit of measure was set correctly on the subject meter.The cca confirmed the test strip vial was intact and the test strips had been stored correct and were not expired or opened past their discard date.The cca noted the patient did not have control solution available to perform a quality control test.Replacement products were sent to the patient.This complaint is being reported because the patient reportedly developed signs/symptoms suggestive of a serious injury adverse event after changing treatment, on the advice of their hcp, based on alleged inaccurate high results obtained with the subject meter.
|